Modulation of Blood Pressure by Central Melanocortinergic Pathways
New England Journal of Medicine2008Vol. 360(1), pp. 44–52
Citations Over TimeTop 1% of 2008 papers
Jerry R. Greenfield, Jeffrey W. Miller, Julia M. Keogh, Elana Henning, Julie Satterwhite, Gregory S. Cameron, B Astruc, John P. Mayer, Søren Brage, Teik Choon See, David J. Lomas, Stephen O’Rahilly, I. Sadaf Farooqi
Abstract
Results of our genetic and pharmacologic studies implicate melanocortinergic signaling in the control of human blood pressure through an insulin-independent mechanism.
Related Papers
- → Exogenous Glucocorticoids and a High-Fat Diet Cause Severe Hyperglycemia and Hyperinsulinemia and Limit Islet Glucose Responsiveness in Young Male Sprague-Dawley Rats(2013)47 cited
- → Mechanisms of Impaired Growth Hormone Secretion in Genetically Obese Zucker Rats: Roles of Growth Hormone-Releasing Factor and Somatostatin*(1990)74 cited
- → The Effect of Fasting on Tissue Cyclic cAMP and Plasma Glucagon in the Obese Hyperglycemic Mouse(1975)39 cited
- → Modulation of Adipoinsular Axis in Prediabetic Zucker Diabetic Fatty Rats by Diazoxide(2004)39 cited
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)